Literature DB >> 21358362

Recurrence of vitreous amyloidosis and need of surgical reintervention in Portuguese patients with familial amyloidosis ATTR V30M.

Nuno Melo Beirão1, Eduarda Matos, Idalina Beirão, Paulo P Costa, Paulo Torres.   

Abstract

PURPOSE: Vitreous amyloid deposits are one of the most common ocular manifestations of familial amyloidosis ATTR V30M (FAP-I), which can be the only manifestation of the disease and can appear even after liver transplantation. Removal by vitrectomy is usually performed, but vitreous amyloid recurrence has been frequently reported. This study was undertaken to evaluate the recurrence of vitreous amyloidosis and its relationship with the degree of previous vitreous removal.
METHODS: Fifty-four vitrectomized eyes from 32 patients with FAP-I were evaluated in the course of a follow-up period of 30.7 ± 17.2 months (range, 8-78; median = 30 months). An extensive, as possible, vitrectomy with indentation was performed in 41 eyes (complete), and in the others 13 eyes only a vitrectomy without indentation (incomplete) was performed. The parameters evaluated were the incidence of amyloid deposits and visual outcomes.
RESULTS: A noteworthy visual acuity gain was observed, although a few patients had a subsequent decrease of visual acuity related to new vitreous amyloid deposition in the visual axis. These new amyloid deposits did not occur in eyes that had undergone extensive vitreous removal, but only in nonextensive vitrectomized eyes (P < 0.001).
CONCLUSION: Recurrence of amyloid deposition only occurred in nonextensive vitrectomized eyes and represents a false recurrence associated with incomplete vitrectomy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21358362     DOI: 10.1097/IAE.0b013e318203c0c2

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  9 in total

1.  Bilateral optic neuropathy and intraretinal deposits after pars plana vitrectomy in amyloidosis.

Authors:  Alberto Rossetti; Rossetti Alberto; Luigi Spedicato; Spedicato Luigi; Ambrogio Fassina; Fassina Ambrogio; Daniele Doro; Doro Daniele
Journal:  Indian J Ophthalmol       Date:  2015-01       Impact factor: 1.848

2.  Multimodal retinal imaging in a Chinese kindred with familial amyloid polyneuropathy secondary to transthyretin Ile107Met mutation.

Authors:  W Lv; J Chen; W Chen; P Hou; C P Pang; H Chen
Journal:  Eye (Lond)       Date:  2014-01-31       Impact factor: 3.775

3.  Transthyretin Arg-83 mutation in vitreous amyloidosis.

Authors:  Ling-Yan Chen; Lin Lu; Yong-Hao Li; Hui Zhong; Wang Fang; Li Zhang; Weng-Lin Li
Journal:  Int J Ophthalmol       Date:  2011-06-18       Impact factor: 1.779

4.  Life paths of patients with transthyretin-related familial amyloid polyneuropathy Val30Met: a descriptive study.

Authors:  Alice Lopes; Alexandra Sousa; Isabel Fonseca; Margarida Branco; Carla Rodrigues; Teresa Coelho; Jorge Sequeiros; Paula Freitas
Journal:  J Community Genet       Date:  2017-10-19

5.  Nd:YAG capsulotomy for the management of posterior capsular amyloidosis.

Authors:  Sasha A Mansukhani; Jose S Pulido; Sunil S Khanna
Journal:  Am J Ophthalmol Case Rep       Date:  2018-11-10

6.  Psychopathological Dimensions in Portuguese Subjects with Transthyretin Familial Amyloid Polyneuropathy.

Authors:  Alice Lopes; Isabel Fonseca; Alexandra Sousa; Margarida Branco; Carla Rodrigues; Teresa Coelho; Jorge Sequeiros; Paula Freitas
Journal:  Biomed Hub       Date:  2017-12-13

7.  Contrasting presentations of the same disease: A comparison of two cases of amyloidosis presenting with eyelid involvement.

Authors:  Christian Kim; Brian Simon; Neel Vaidya; Suzanne Kirk; Kimberly Estes; Larissa Ghadiali; Andreas Kontosis; David Yoo
Journal:  Am J Ophthalmol Case Rep       Date:  2022-09-29

8.  Vitreous Amyloidosis as the Presenting Symptom of Familial Amyloid Polyneuropathy TTR Val30Met in a Portuguese Patient.

Authors:  Mariana Seca; Natália Ferreira; Teresa Coelho
Journal:  Case Rep Ophthalmol       Date:  2014-03-15

Review 9.  Ocular Involvement in Hereditary Amyloidosis.

Authors:  Angelo Maria Minnella; Roberta Rissotto; Elena Antoniazzi; Marco Di Girolamo; Marco Luigetti; Martina Maceroni; Daniela Bacherini; Benedetto Falsini; Stanislao Rizzo; Laura Obici
Journal:  Genes (Basel)       Date:  2021-06-22       Impact factor: 4.096

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.